Urosource: Today's Key Article

US research examines biomarkers for prostate cancer detection, recurrence

Filed by: JV

Thursday, 17 May 2012- Alterations to the "on-off" switches of genes occur early in the development of prostate cancer and could be used as biomarkers to detect the disease months or even years earlier than current approaches, according to a Mayo Clinic study conducted in the US.

These...

Interactive

Characteristics of bladder cancer after radiotherapy for prostate cancer

Wednesday, 16 May 2012- Prostate radiotherapy (RT) has been associated with an increased risk of bladder cancer (CaB). However it is unknown how prior RT affects the stage, grade, and histology of secondary CaB. While irradiated patients have adverse surgical outcomes, how RT affects survival is...

Filed by: JV

Simple urine test predicts AKI in sepsis patients

Tuesday, 15 May 2012- A simple and inexpensive urine test appears to predict which sepsis patients will go on to develop an acute kidney injury (AKI), researchers said here.

Patients who were found to have de novo dipstick proteinuria had a significantly higher risk of AKI (P=0.001), Dr. Javier...

Filed by: JV

More key articles

Assessing the safety of extraperitoneal laparoscopic radical prostatectomy: a Chinese study

Monday, 14 May 2012- Although many midterm oncologic data have been reported for extraperitoneal laparoscopic radical prostatectomy (ELRP) in western countries, few oncologic data of the extraperitoneal procedure was published in China.

X. Li and colleagues conducted a study to evaluate the...

Biopsy-detectable prostate cancer using the Prostate Cancer Prevention Trial Risk Calculator

Friday, 11 May 2012- In a study conducted by Y. Liang and colleagues, the risks of prostate cancer (CaP) and high-grade CaP were evaluated using the Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) in an age-stratified random sample of 1,021 Caucasian and African-American men with no...

More headline news

Selenium, Vitamin E: no preventive effect in men with bladder cancer

Monday, 14 May 2012- Epidemiological and biological evidence suggests a preventive effect of selenium and vitamin E on bladder cancer.

Y. Lotan and colleagues assessed the effect of selenium and/or vitamin E on bladder cancer development. They published their findings in a recent...

Honeybee hive substance slows prostate tumor cell growth, says US research

Friday, 11 May 2012- An over-the-counter natural remedy derived from honeybee hives arrests the growth of prostate cancer cells and tumors in mice, according to a new paper from researchers at the University of Chicago Medicine.

Caffeic acid phenethyl ester, or CAPE, is a compound isolated from...

More conference reports

Urology in Maghreb region developing rapidly

Wednesday, 7 March 2012- Urology in the Maghreb region has seen rapid growth in recent years, prompting urological experts and leaders from Morrocco, Tunesia and Algeria to bond together and join for the first time this year’s Urology Beyond Europe programme at the 27th Annual EAU Congress held...

Top EAU honours for Marberger, Wickham and Hautmann

Tuesday, 6 March 2012- Professors Michael Marberger (AT), John Wickham (UK) and Richard Hautmann (DE) received top honours from the European Association of Urology (EAU) during the recently held 27th Annual EAU Congress in Paris.

Marberger received the Willy Gregior Medal for his contributions to...

More upcoming

Programme app for 27th Annual EAU Congress available for download

Tuesday, 14 February 2012- The iPhone App Store and Android Market feature the EAU Congress application (app), and congress participants are encouraged to download the application as it provides a handy and more convenient way to track events during the five-day meeting.

To be held from February...

Vienna, Austria: 26th Annual EAU Congress tackles controversial issues in urology

Wednesday, 9 March 2011- Some of the most pressing issues in urology will be addressed next week during the 26th Annual EAU Congress in Vienna, Austria, from March 18 to 22. Four plenary sessions, which will open each of the congress days, will examine issues in uro-oncology, andrology, paediatric...